| Independent variables | TgAb Negative n (%)/Mean ± SD | TgAb Positive n (%)/Mean ± SD | Total | p-value | |
| Age (years)@ | 41.36 ± 13.88 | 41.23 ± 13.49 | 41.28 ± 13.59 | 0.919 | |
| Sex# |
| ||||
| Male | 6 (46.2) | 7 (53.8) | 13 (11.9) | 0.650 | |
| Female | 38 (39.6) | 58 (60.4) | 96 (88.1) | ||
| Stage at diagnosis# |
|
|
|
| |
| 0 | 1 (100) | 0 | 1 (0.9) | 0.513 | |
| I | 41 (40.2) | 61 (59.8) | 102 (93.6) | ||
| II | 2 (50) | 2 (50) | 4 (3.7) | ||
| III | 0 | 1 (100) | 1 (0.9) | ||
| Stage IV b |
| 1 (100) | 1 (0.9) | ||
| Pathology# |
|
|
|
| |
| Papillary | 36 (37.1) | 61 (62.9) | 97 (89) | 0.079 | |
| Follicular | 5 (83.3) | 1 (16.7) | 6 (5.5) | ||
| Poorly Differentiated | 1 (25) | 3 (75) | 4 (3.7) | ||
| Hurthle cell cancer | 1 (100) | 0 | 1 (0.9) | ||
| NIFTP | 1 (100) | 0 | 1 (0.9) | ||
| Variant# |
| ||||
| Classical PTC | 13 (52) | 12 (48) | 25 (22.9) | 0.510 | |
| Follicular PTC | 8 (42.1) | 11 (57.9) | 19 (17.4) | ||
| Tall cell variant | 0 | 1 (100) | 1 (0.9) | ||
| Columnar | 0 | 1 (100) | 1 (0.9) | ||
| Papillary microcarcinoma | 14 (38.9) | 22 (61.1) | 36 (33) | ||
| Follicular cancers and others | 7 (63.6) | 4 (36.4) | 11 (10.1) | ||
| Vascular invasion# |
|
|
|
| |
| Papillary | None | 34 (38.6) | 54 (61.4) | 88 (80.7) | 0.211 |
| Present | 3 (30) | 7 (70) | 10 (9.2) | ||
| Follicular | Minimally invasive | 2 (100) | 0 | 2 (1.8) | |
| Encapsulated angioinvasive | 2 (66.7) | 1 (33.3) | 3 (2.8) | ||
| Widely invasive | 1 (100) | 0 | 1 (0.9) | ||